Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer

BACKGROUND: Despite recent progress in the identification of genetic and molecular alterations in prostate cancer, markers associated with tumor progression are scarce. Therefore precise diagnosis of patients and prognosis of the disease remain difficult. This study investigated novel molecular mark...

Descripción completa

Detalles Bibliográficos
Autores principales: Pressinotti, Nicole Chui, Klocker, Helmut, Schäfer, Georg, Luu, Van-Duc, Ruschhaupt, Markus, Kuner, Ruprecht, Steiner, Eberhard, Poustka, Annemarie, Bartsch, Georg, Sültmann, Holger
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807430/
https://www.ncbi.nlm.nih.gov/pubmed/20035634
http://dx.doi.org/10.1186/1476-4598-8-130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807430/
https://www.ncbi.nlm.nih.gov/pubmed/20035634
http://dx.doi.org/10.1186/1476-4598-8-130

Ejemplares similares